Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "WOKADINE-acquisition"

1 News Found

CORONA Remedies posts robust FY26 with 17.3% revenue growth, 33.4% PAT surge
News | May 12, 2026

CORONA Remedies posts robust FY26 with 17.3% revenue growth, 33.4% PAT surge

The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market